YOLFTbeta
Chongqing Zhifei Bio Products

Chongqing Zhifei Bio Products

300122 · SHE · Healthcare / Biotechnology

13.85CNY+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close13.85
Open13.83
Day Range13.72 – 14.26
52-Week Range11.07 – 22.18
Volume27.68M
Market Cap33.47B
P/E (TTM)0.00
Forward P/E41.15
EPS-6.24
Dividend Yield0.00%
Beta0.46
50-Day Avg13.14
200-Day Avg14.95

About

Chongqing Zhifei Biological Products Co., Ltd., a biopharmaceutical company, engages in the research and development, production, sale, and distribution of vaccine and biological products in China. The company offers recombinant COVID-19 vaccine; recombinant mycobacterium tuberculosis fusion protein products; group A and C meningococcal polysaccharide vaccine; ACYW135 meningococcal polysaccharide vaccine; Haemophilus Influenza type B conjugate vaccine; mycobacterium injection under the Vaccae brand; and meningococcal group A and C conjugate vaccine. It also provides cold storage, refrigerated vehicles, and cold roll boxes; and customs clearance and registration of imported vaccines. The company was founded in 2002 and is based in Chongqing, China.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Lingfeng Jiang
  • Employees6.29K
  • HeadquartersBuilding T1, IFS, Chongqing, China, 400020, China
  • Websitehttps://www.zhifeishengwu.com

Leadership

  • Mr. Lingfeng JiangVice Chairman of the Board & President · b. 1980
  • Mr. Zhen Jing Li CPAVP, CFO & Director · b. 1982
  • Mr. Zhijun WangChief Engineer · b. 1966
  • Mr. Fei QinVP, Secretary of Board & Director · b. 1986
  • Ms. Yu ZhangVice president · b. 1987
  • Ms. Zhang JingVice President · b. 1969
  • Mr. Jie ShaoVice President · b. 1987
  • Ms. Hong FanVice President · b. 1988
  • Ms. Li XieVice President · b. 1982
  • Mr. Xi Sheng JiangVice President · b. 1960

Financials

Income Statement

Currency: CNY2007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue492.43M590.34M604.05M737.31M628.74M760.33M780.18M800.94M712.74M445.95M1.34B5.23B10.59B15.19B30.65B38.26B52.92B26.07B8.96B
Growth (%)-+19.88%+2.32%+22.06%-14.73%+20.93%+2.61%+2.66%-11.01%-37.43%+201.06%+289.43%+102.50%+43.48%+101.79%+24.83%+38.30%-50.74%-65.64%
Cost of Revenue207.38M214.85M188.50M269.31M250.59M341.35M335.72M316.55M144.71M59.50M322.03M2.38B6.15B9.32B15.73B25.52B38.99B18.97B8.26B
Gross Profit277.82M375.48M415.54M468.01M378.15M418.98M444.46M484.39M568.03M386.45M1.02B2.85B4.43B5.87B14.92B12.75B13.93B7.10B702.74M
Gross Margin56.42%63.60%68.79%63.47%60.14%55.11%56.97%60.48%79.70%86.66%76.01%54.45%41.87%38.67%48.69%33.31%26.33%27.23%7.84%
Operating Expense98.19M154.10M158.03M174.10M223.40M238.11M294.78M312.31M347.40M357.49M508.29M1.13B1.62B1.98B2.92B3.99B4.56B4.83B3.72B
Operating Income179.63M221.38M257.51M293.91M154.75M180.87M149.68M172.07M220.63M28.96M512.24M1.71B2.81B3.90B12.00B8.76B9.37B2.26B-3.02B
Operating Margin36.48%37.50%42.63%39.86%24.61%23.79%19.19%21.48%30.96%6.49%38.15%32.76%26.57%25.64%39.15%22.89%17.71%8.68%-33.73%
EBITDA190.20M231.22M274.76M318.11M249.08M202.74M147.46M180.33M231.49M65.31M553.93M1.80B2.95B4.13B12.30B9.00B9.52B2.71B-16.65B
EBITDA Margin38.62%39.17%45.49%43.14%39.62%26.66%18.90%22.52%32.48%14.64%41.26%34.51%27.91%27.20%40.12%23.53%17.99%10.40%-185.82%
Net Income152.01M190.05M231.59M256.79M196.38M215.05M130.35M148.00M197.40M32.52M432.28M1.45B2.37B3.30B10.21B7.54B8.07B2.02B-14.72B
Net Income Margin30.87%32.19%38.34%34.83%31.23%28.28%16.71%18.48%27.70%7.29%32.20%27.76%22.35%21.73%33.30%19.70%15.25%7.74%-164.35%
R&D---15.18M22.81M21.77M33.26M39.04M58.27M58.89M78.38M142.94M169.55M299.65M552.63M854.16M968.47M986.27M932.30M
R&D as % of Total Revenue---2.06%3.63%2.86%4.26%4.87%8.17%13.21%5.84%2.73%1.60%1.97%1.80%2.23%1.83%3.78%10.41%
Interest Expense162.66K351.72K143.18K139.24K156.13K239.88K25.01M77.83K42.37K39.84K7.86M36.45M87.68M146.45M73.19M75.29M117.44M177.64M331.04M
Interest Expense % of Total Revenue0.03%0.06%0.02%0.02%0.02%0.03%3.21%0.01%0.01%0.01%0.59%0.70%0.83%0.96%0.24%0.20%0.22%0.68%3.70%

Balance Sheet

Currency: CNY2007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets332.30M390.10M518.02M2.21B2.40B2.50B2.59B2.71B2.68B2.71B4.11B6.81B10.94B15.22B30.05B38.00B50.23B49.91B31.72B
Total Liabilities144.27M123.05M66.33M67.59M146.22M130.53M198.61M256.72M212.40M188.21M1.17B2.63B5.20B6.97B12.39B13.77B18.73B19.08B15.61B
Total Equity188.03M267.06M451.69M2.14B2.26B2.37B2.39B2.46B2.47B2.52B2.94B4.18B5.75B8.25B17.66B24.24B31.51B30.83B15.84B
Cash137.48M61.52M181.94M1.62B1.45B1.27B1.21B1.02B809.07M658.48M874.10M769.43M1.15B1.44B4.31B2.62B6.34B2.70B2.63B
Total Debt-5.00M8.00M----54.38M891.51K1.51M260.00M621.01M2.38B2.88B817.51M2.02B2.99B12.26B-
Net Debt-137.48M-56.52M-173.94M-1.62B-1.45B-1.27B-1.21B-966.68M-809.07M-656.97M-614.10M-148.42M1.23B1.44B-3.49B-598.74M-3.35B9.56B8.88B

Cash Flow

Currency: CNY2007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow111.66M141.58M210.61M54.19M221.25M112.89M221.58M161.39M223.45M89.95M203.61M585.59M1.37B3.50B8.51B1.99B9.00B-4.41B5.17B
Investing Cash Flow-34.76M-136.24M-43.49M-39.46M-306.25M-194.74M-198.10M-336.91M-336.54M-151.78M-250.65M-493.14M-622.73M-896.88M-2.02B-1.50B-976.60M-925.58M-
Financing Cash Flow-13.16M-81.31M-46.70M1.42B-80.02M-100.03M-82.00M-13.87M-213.89M24.87M142.22M-288.42M-392.80M-2.11B-3.59B-2.17B-4.29B1.70B-
Capital Expenditure24.76M35.89M11.87M51.51M309.56M199.06M201.37M276.96M225.72M308.05M230.85M479.82M572.93M826.98M1.93B1.45B1.13B930.34M619.19M
Free Cash Flow86.90M105.70M198.74M2.68M-88.31M-86.16M20.21M-115.57M-2.27M-218.09M-27.24M105.77M794.06M2.67B6.58B535.93M7.86B-5.34B4.55B
Dividends Paid8.16M83.22M46.70M139.24K72.11M90.02M120.00M80.44M82.14M80.00M23.46M234.13M800.00M800.00M861.96M1.01B889.29M2.53B344.81M
FCF to OCF77.83%74.65%94.36%4.94%-39.92%-76.32%9.12%-71.61%-1.01%-242.45%-13.38%18.06%58.09%76.35%77.29%26.94%87.39%121.08%88.02%
Dividend Paid to FCF9.39%78.74%23.50%5.20%-81.65%-104.48%593.76%-69.60%-3623.70%-36.68%-86.15%221.36%100.75%29.97%13.11%189.39%11.31%-47.30%7.58%

Earnings

Report DateSep 30, 2010Dec 31, 2010Mar 31, 2011Aug 31, 2011Nov 30, 2011Feb 29, 2012May 30, 2012Aug 29, 2012Nov 28, 2012Feb 27, 2013May 29, 2013Aug 28, 2013Nov 27, 2013Feb 26, 2014May 28, 2014Aug 16, 2014Oct 24, 2014Feb 25, 2015Apr 21, 2015Aug 24, 2015Oct 26, 2015Feb 27, 2016Apr 24, 2016Aug 16, 2016Oct 19, 2016Feb 27, 2017Apr 24, 2017Aug 14, 2017Oct 22, 2017Feb 26, 2018Apr 25, 2018Aug 13, 2018Oct 18, 2018Apr 28, 2019Aug 29, 2019Oct 21, 2019Feb 27, 2020Apr 28, 2020Aug 3, 2020Oct 15, 2020Feb 21, 2021Apr 20, 2021Aug 29, 2021Oct 28, 2021Feb 8, 2022Apr 27, 2022Aug 29, 2022Oct 27, 2022Mar 20, 2023Apr 19, 2023Aug 28, 2023Oct 26, 2023Mar 11, 2024Apr 22, 2024Aug 29, 2024Oct 25, 2024Dec 31, 2024Apr 21, 2025Aug 18, 2025Oct 30, 2025Dec 31, 2025Apr 27, 2026Aug 28, 2026
EPS Estimate---------------------------0.070.090.10---0.120.29-----0.46-0.790.980.350.850.721.211.170.810.791.050.861.110.820.630.100.340.090.04-2.38-0.040.02
EPS Actual0.020.030.010.030.010.030.010.030.010.030.020.030.01-0.000.020.030.030.000.030.040.030.020.04-0.03-0.000.020.040.070.070.090.160.260.250.220.270.390.380.320.620.610.510.511.901.820.730.790.761.171.210.850.930.910.640.610.32-0.03-0.06-0.13-0.12-0.25-5.65-0.16-0.18
Surprise---------------------------0.00%-22.22%-10.00%---83.33%-6.90%-----10.87%-140.51%85.71%108.57%-7.06%5.56%-3.31%3.42%4.94%17.72%-13.33%-25.58%-45.05%-60.98%-104.76%-160.00%-138.24%-233.33%-752.74%-137.37%-300.00%-1000.00%
Timing---------------Pre-marketPre-market-Pre-marketPre-marketAfter-hoursAfter-hoursPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketAfter-hoursAfter-hoursPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursPre-marketPre-marketPre-marketAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursPre-market-After-hoursAfter-hours--After-hoursAfter-hours

Key Statistics & Ratios

Market Cap33.47B
Enterprise Value40.26B
Trailing P/E0.00
Forward P/E41.15
PEG Ratio0.00
Price / Sales4.16
Price / Book2.14
EPS-6.24
Book Value6.28
Revenue (TTM)8.05B
Gross Profit (TTM)-13.33B
EBITDA-16.84B
Profit Margin-185.33%
Operating Margin-26.69%
Return on Equity-65.69%
Return on Assets-29.42%
Shares Outstanding2.39B
Shares Float990.07M
Beta0.46
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20242×
0.20Dec 25, 20240.80Aug 8, 2024
20231×
0.50Jun 16, 2023
20221×
0.39Jul 15, 2022
20211×
0.32Aug 6, 2021
20201×
0.32Aug 12, 2020
20191×
0.32Jun 24, 2019
20181×
0.08Jun 7, 2018
20171×
0.01May 15, 2017
20161×
0.03May 13, 2016
20151×
0.03May 28, 2015
20141×
0.03May 28, 2014
20131×
0.05May 23, 2013
20121×
0.04Apr 26, 2012
20111×
0.03Apr 14, 2011

Stock Splits

  • Jun 16, 20231.54:1
  • May 13, 201620:10
  • May 28, 201420:10